Healthtech Startups

Access TeleCare provides a telemedicine platform and cart hardware that connects hospitals and their patients with remote specialists for acute specialty care and behavioral health. Founded by physicians, it designs custom virtual care delivery programs for hospitals along with 24/7 U.S.-based technical support.

1 investor

Access2Bone develops bone graft products containing human tissue-based compositions for orthopedic surgeries. The company's offerings are designed for foot, ankle, and spine fusion procedures.

1 investor

Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies. The company is led by experienced biotech entrepreneurs and scientific experts with a track record in bringing immunological oncology projects to clinical development.

1 investor

Rosarium Health provides comprehensive home accessibility and modification services, including safety evaluations and fall prevention, blending clinical expertise with insurance coordination for independent living. The company serves individuals and families seeking to age in place or improve home accessibility through modifications and professional assessment.

1 investor

Accuity provides software solutions to hospitals for managing clinical documentation standards, regulatory compliance, and healthcare revenue cycle optimization. The company serves over 400 hospital clients across the United States.

1 investor

Accunea develops organ condition monitoring technology that tracks biomarkers of kidney function and metabolism before and after transplantation, providing clinicians with continuous point-of-care data and AI-driven trend analysis. It serves transplant centres and clinicians to assess organ viability and support patient recovery, and integrates with hospital EPR systems.

1 investor

Accuryn develops a monitoring system for detecting acute kidney injury and catheter-associated urinary tract infections in hospitalized patients, particularly in critical care settings.

1 investor

Accushield provides a visitor management and third-party caregiver credentialing platform for senior living communities, skilled nursing facilities, and healthcare environments. Its kiosk and software handle digital sign-in, caregiver verification, third-party care reporting, evacuation management, and family feedback, serving communities across all 50 US states and Canada.

1 investor

ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.

1 investor

Acepodia develops cell therapies for cancer treatment, leveraging proprietary immune cell engineering and tumor-targeting technology to create off-the-shelf therapeutic options for broad patient populations.

1 investor

1 investor

Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies. The company serves rare disease patients and their families globally.

1 investor

Acqumen Medical develops a non-invasive hemodynamic monitoring system that uses ultrasound to measure cardiac parameters in pediatric and neonatal critical care patients. Its technology is aimed at clinicians treating patients of any size to detect instability early and guide targeted therapy.

1 investor

Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits. The technology is aimed at human therapeutics for genetic diseases and is offered for licensing.

1 investor

Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.

1 investor

A dental implant restoration provider offering single-tooth and full-arch prosthetic solutions for patients seeking functional and aesthetic implant replacements.

1 investor

Activ'Inside develops proprietary food supplement active ingredients for neuronutrition and nutricosmetics applications, supported by scientific research and clinical studies. The company supplies branded ingredients and botanical extracts to manufacturers formulating nutraceutical products.

1 investor

ActiveAging offers an AI-powered management platform for Medicare Advantage health plans that uses data insights and remote monitoring to tailor benefits to aging members' needs while reducing health deterioration and financial risk. The solution comprises a member mobile app and health plan dashboard designed to improve member engagement, retention, and health outcomes.

1 investor

Walkabouts is an online, on-demand platform that turns movement breaks into standards-based lessons, helping teachers integrate physical activity into core academic instruction. It serves K-12 educators and is correlated to state and national standards to support whole-child development and student engagement.

1 investor

ActivKare sells incontinence products and mobility aids for people recovering from physical setbacks, with same-day or next-day shipping and insurance coverage assistance.

1 investor

Actiz provides a LIMS (Laboratory Information Management System) platform for laboratories, including quality control labs and service-provider labs, to reduce manual transcription, speed up reporting, and support traceability and ISO/IEC 17025 compliance. The software serves clients across food, pharmaceutical, and agricultural sectors in Brazil and other countries.

1 investor

Actus Nutrition manufactures and supplies protein, fat, and functional nutritional ingredients derived from milk and whey for food and beverage manufacturers. The company serves the food industry with branded ingredient solutions including casein proteins, whey proteins, and specialty dairy components.

1 investor

ActX provides genomic decision support that is integrated directly into electronic health record systems, allowing clinicians to check prescriptions for efficacy, adverse reactions, and dosing based on a patient's genetics. The company also offers genetic screening and reporting for individuals, providers, practices, and health systems, including analysis of existing 23andMe data.

1 investor

Actym Therapeutics engineers bacteria as a delivery system for therapeutics targeting cancer and fibrotic disease. Its approach uses engineered S. Typhimurium to systemically administer and locally produce multiple therapeutic payloads at the disease site to reduce systemic toxicity.

1 investor